Cambridge Investment Research Advisors, Inc.
Position in PCRX — Pacira BioSciences, Inc.
CIK 1419186
FAIRFIELD, IA
Position in PCRX
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$3,247,258
+$472,837 QoQ
Shares Held
127,996
+4.3% QoQ
Ownership
0.321%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#53
of 253 holders
Holding Since
Mar 2020
5 quarters on record
Common Shares in PCRX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Cambridge Investment Research Advisors, Inc. holds $28,058,357 across 19 Drug Manufacturers - Specialty & Generic names. PCRX ranks #2 (11.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LNTH |
Lantheus Holdings, Inc.
|
64,199 | $7,122,237 | |
| 2 | PCRX |
Pacira BioSciences, Inc.
This page
|
127,996 | $3,247,258 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
5,625 | $3,047,793 | |
| 4 | TEVA |
Teva Pharmaceutical Industries Ltd
|
87,650 | $2,969,582 | |
| 5 | HIMS |
Hims & Hers Health, Inc.
|
79,024 | $2,739,762 | |
| 6 | ZTS |
Zoetis Inc.
|
34,463 | $2,476,511 | |
| 7 | VTRS |
Viatris Inc
|
140,952 | $2,238,317 | |
| 8 | NBIX |
Neurocrine Biosciences Inc
|
6,718 | $1,132,251 |
All Filings in PCRX
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,247,258 | 127,996 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $2,774,421 | 122,762 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $2,721,152 | 105,145 | Shares | Sole | 2026-02-05 | |
| 2020-06-30 | $231,917 | 4,420 | Shares | Sole | 2020-07-27 | |
| 2020-03-31 | $269,178 | 8,028 | Shares | Sole | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||